🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge
Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.

Cohort profile: COVID-19 in a cohort of pregnant women and their descendants, the MOACC-19 study

10.1101/2020.08.20.20178657Source: DataRank Database

Cohort profile: COVID-19 in a cohort of pregnant women and their descendants, the MOACC-19 study is a dataset. On theSindex it has a DataRank of 0, placing it in the top 100% of the data-sharing corpus.

Top 100%percentile
0DataRank
0Top 100%
Dataset0 citations · base score 0
Cite:
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Abstract

ABSTRACT Purpose The Mother and Child Covid-19 study is a cohort recruiting pregnant women and their children in Cantabria, North of Spain, during COVID-19 pandemic in order to ascertain Consequences of SARS-CoV-2 infection on pregnant women and their descendants. This article reports the cohort profile and preliminary results as recruitment is still open. Participants Three sub-cohorts can be identified at recruitment. Sub-cohort 1 includes women giving birth between 23 rd March and 25 th May 2020; they have been retrospectively recruited and could have been exposed to COVID-19 only in their third trimester of pregnancy. Sub-cohort 2 includes women giving birth from 26 th May 2020 on; they are being prospectively recruited and could have been exposed to COVID-19 in both their second and third trimesters of pregnancy. Sub-cohort 3 includes women in their 12 th week of pregnancy prospectively recruited from 26 th May 2020 on; they could have been exposed to COVID-19 anytime in their pregnancy. All women are being tested for SARS-CoV-2 infection using both RT-PCR for RNA detection and ELISA for anti-SARS-CoV-2 antibodies. All neonates are being tested for antibodies using immunochemoluminiscency tests; if the mother is tested positive for SARS-CoV-2 RNA, a naso-pharyngeal swab is also obtained from the child for RT-PCR analysis. Findings to date As of 22 nd October, 1167 women have been recruited (266, 354 and 547 for sub-cohorts 1, 2 and 3, respectively). Fourteen women tested positive to SARS-CoV-2 RNA by the day of delivery. All fourteen children born from these women tested negative for SARS-CoV-2 RNA. Future plans Children from women included in sub-cohort 3 are expected to be recruited by the end of 2020. Children will be followed-up for one year in order to ascertain the effect that COVID-19 on their development. ARTICLE SUMMARY Strengths and limitations Strengths This cohort would ascertain the effect of COVID-19 in both mother and children whatever the trimester of the infection. It would also compare health care provided to pregnant women during the COVID-19 pandemic with that provided in the same hospital before the emergence of COVID-19. The cohort is recruited in Spain, one of the developed countries earlier and more affected by COVID-19. Limitations The study could be underpowered according to the prevalence reported in a Spanish national study. Information regarding exposure to people infected by SARS-CoV-2 or risk activities is self-reported.

Data sources & pipeline
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Pending

FAIR Checklist

Context only (not used in score)
Findable (1/2)
  • Has DOI
Accessible (0/2)
    Interoperable (0/2)
      Reusable (1/3)
      • Dataset classification

      FAIR checklist signals are shown for context only and do not affect DataRank scoring.

      Authors (22)

      Carolina Lechosa-Muñiz,Pilar Gortázar,María Fernández-Ortiz,Yolanda Jubete,María J. Cabero

      Related Papers (9)

      International Journal of Epidemiology(2014)
      OpenAlex related
      10.1093/ije/dyu184
      Indian Journal of Endocrinology and Metabolism(2012)
      OpenAlex related
      10.4103/2230-8210.104113